The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

NCT01921972 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

232

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Galantamine CR
DRUG: Memantine
DRUG: Placebo

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]